Otis Selected As Elevator and Escalator Supplier for Kaohsiung MRT Red Line Extension
TAIPEI, April 2, 2025 /PRNewswire/ -- Otis Taiwan will supply 65 elevators and escalators for the extension of the Kaohsiung MRT Red Line RLC01, expanding its presence in the city's transportation network. Otis Taiwan is part of Otis Worldwide...
Eoptolink Demonstrates 1.6T LRO Modules at OFC 2025
SAN FRANCISCO, March 31, 2025 /PRNewswire/ -- Eoptolink Technology Inc., Ltd. (SZSE: 300502), a leading innovator and provider of advanced optical transceiver solutions, is demonstrating its 1.6T LRO transceiver operating at 212Gb/s per lambda...
Clinical Study demonstrates Kerry Group Supplement Solution Sensoril® Ashwagandha Supports Quality of Life for Post-Menopausal Women
Sensoril® Ashwagandha is among Kerry's portfolio of solutions tailored to meet women's unique health needs SINGAPORE, March 31, 2025 /PRNewswire/ -- Sensoril® ashwagandha — a science-backed ingredient by Kerry Group — has been shown to support...
Hyundai ADM Demonstrates Anti-Metastatic Effect of 'PenetriumTM' in TNBC Preclinical Study
– Simultaneous treatment of primary and metastatic tumors by eliminating pseudo-resistance SEOUL, South Korea, March 27, 2025 /PRNewswire/ -- Hyundai ADM Bio (KOSDAQ symbol 187660) announced on the 24th that its first-in-class...
Patent Index 2024: Patent applications from China at record level
European Patent Office received nearly 200 000 patent applications last year, with 10.1% coming from China China ranks 4th globally in European patent applications Huawei is No.2 among top applicant companies China recorded a 0.5% YoY increase in...
Everest Medicines Announces FDA Clearance of IND Application for Tumor-Associated Antigen Vaccine EVM14
EVM14 received U.S. FDA clearance for its IND application, becoming Everest's first internally discovered program, and the first mRNA therapeutic cancer vaccine to be cleared for global clinical development. Preclinical highlights： EVM14 induced a...
Akeso's Cadonilimab Combined with Concurrent Chemoradiotherapy Demonstrates Promising Efficacy in Locally Advanced Cervical Cancer: Data Published at the 2025 SGO Annual Meeting
HONG KONG, March 21, 2025 /PRNewswire/ -- Akeso Inc. (9926.HK) presented promising phase III safety run-in results from the COMPASSION-18/AK104-305 study, at the 2025 Annual Meeting of the Society of Gynecologic Oncology (SGO). The study evaluates...
Siemens Applauded by Frost & Sullivan for Supporting the Evolution of Smart Hospitals and Its Market-leading Position
Siemens strengthens its leadership position in the healthcare sector with its competency in digitalizing facilities and operations, thus enabling the progression of smart hospitals. SAN ANTONIO, March 19, 2025 /PRNewswire/ -- Frost & Sullivan...
TaiMed Biologics Announces Results from Late-Breaking Phase 2a Data on Long-Acting HIV Maintenance Therapy at CROI 2025
TMB-365/TMB-380 Combination Demonstrates Viral Suspension Without the Need for Susceptibility Screening TaiMed Biologics will reshape HIV treatment management and seeks strategic collaborations with global pharmaceutical partners for the...
MicroCloud Hologram Inc. Researches a Continuous Control Modulation-Based Two-Qubit (Two Quantum Bits) Dephasing Noise Spectral Protocol
SHENZHEN, China, March 12, 2025 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, they proposed a two-qubit dephasing noise spectral protocol based on continuous control modulation,...